John Mendelsohn
MD
Historical: Former President, MD Anderson Cancer Center
👥Biography 个人简介
John Mendelsohn developed the concept of targeting the EGF receptor for cancer therapy and co-invented cetuximab which became one of the first approved monoclonal antibodies for solid tumors. He served as President of MD Anderson Cancer Center from 1996 to 2011 and founded its Institute for Personalized Cancer Therapy. His leadership shaped modern precision oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 John Mendelsohn 的研究动态
Follow John Mendelsohn's research updates
留下邮箱，当我们发布与 John Mendelsohn（MD Anderson Cancer Center (historical)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment